Template:Hormone levels with medroxyprogesterone acetate
Jump to navigation
Jump to search
Hormone levels with medroxyprogesterone acetate
-
![MPA levels with 2.5 or 5 mg/day oral MPA in combination with 1 or 2 mg/day estradiol valerate (Indivina) in postmenopausal women.[1]](https://upload.wikimedia.org/wikipedia/commons/thumb/d/d3/Levels_of_medroxyprogesterone_acetate_with_2.5_or_5_mg_per_day_oral_medroxyprogesterone_acetate_in_postmenopausal_women.png/400px-Levels_of_medroxyprogesterone_acetate_with_2.5_or_5_mg_per_day_oral_medroxyprogesterone_acetate_in_postmenopausal_women.png)
MPA levels with 2.5 or 5 mg/day oral MPA in combination with 1 or 2 mg/day estradiol valerate (Indivina) in postmenopausal women.[1]
-
![MPA levels after a single 150 mg intramuscular injection of MPA (Depo-Provera) in aqueous suspension in women.[2][3]](https://upload.wikimedia.org/wikipedia/commons/thumb/5/52/Medroxyprogesterone_acetate_levels_after_a_single_150_mg_intramuscular_injection_of_medroxyprogesterone_acetate_in_women.png/400px-Medroxyprogesterone_acetate_levels_after_a_single_150_mg_intramuscular_injection_of_medroxyprogesterone_acetate_in_women.png)
MPA levels after a single 150 mg intramuscular injection of MPA (Depo-Provera) in aqueous suspension in women.[2][3]
-
![MPA levels after a single 25 to 150 mg intramuscular injection of MPA (Depo-Provera) in aqueous suspension in women.[2][4]](https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Medroxyprogesterone_acetate_levels_after_a_single_intramuscular_injection_of_different_doses_of_medroxyprogesterone_acetate_in_women.png/400px-Medroxyprogesterone_acetate_levels_after_a_single_intramuscular_injection_of_different_doses_of_medroxyprogesterone_acetate_in_women.png)
MPA levels after a single 25 to 150 mg intramuscular injection of MPA (Depo-Provera) in aqueous suspension in women.[2][4]
-
![MPA levels after a single 104 mg subcutaneous injection of MPA (Depo-SubQ Provera) in aqueous suspension in women.[5]](https://upload.wikimedia.org/wikipedia/commons/thumb/f/f0/Medroxyprogesterone_acetate_levels_with_a_subcutaneous_injection_of_104_mg_medroxyprogesterone_acetate_in_women.png/400px-Medroxyprogesterone_acetate_levels_with_a_subcutaneous_injection_of_104_mg_medroxyprogesterone_acetate_in_women.png)
MPA levels after a single 104 mg subcutaneous injection of MPA (Depo-SubQ Provera) in aqueous suspension in women.[5]
![MPA levels with 2.5 or 5 mg/day oral MPA in combination with 1 or 2 mg/day estradiol valerate (Indivina) in postmenopausal women.[1]](/wiki/File:Levels_of_medroxyprogesterone_acetate_with_2.5_or_5_mg_per_day_oral_medroxyprogesterone_acetate_in_postmenopausal_women.png)
![MPA levels after a single 150 mg intramuscular injection of MPA (Depo-Provera) in aqueous suspension in women.[2][3]](/wiki/File:Medroxyprogesterone_acetate_levels_after_a_single_150_mg_intramuscular_injection_of_medroxyprogesterone_acetate_in_women.png)
![MPA levels after a single 25 to 150 mg intramuscular injection of MPA (Depo-Provera) in aqueous suspension in women.[2][4]](/wiki/File:Medroxyprogesterone_acetate_levels_after_a_single_intramuscular_injection_of_different_doses_of_medroxyprogesterone_acetate_in_women.png)
![MPA levels after a single 104 mg subcutaneous injection of MPA (Depo-SubQ Provera) in aqueous suspension in women.[5]](/wiki/File:Medroxyprogesterone_acetate_levels_with_a_subcutaneous_injection_of_104_mg_medroxyprogesterone_acetate_in_women.png)
Template documentationSee also
References
- ↑ Järvinen, Asko; Kainulainen, Petri; Nissilä, Minna; Nikkanen, Hanna; Kela, Marjo (2004). "Pharmacokinetics of estradiol valerate and medroxyprogesterone acetate in different age groups of postmenopausal women". Maturitas. 47 (3): 209–217. doi:10.1016/j.maturitas.2003.01.001. ISSN 0378-5122.
- ↑ 2.0 2.1 Goebelsmann, Uwe (1986). "Pharmacokinetics of Contraceptive Steroids in Humans". In A. T. Gregoire; Richard P. Blye (eds.). Contraceptive Steroids: Pharmacology and Safety. Springer Science & Business Media. pp. 67–111. doi:10.1007/978-1-4613-2241-2_4. ISBN 978-1-4613-2241-2.
- ↑ Ortiz A, Hirol M, Stanczyk FZ, Goebelsmann U, Mishell DR (January 1977). "Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA". J. Clin. Endocrinol. Metab. 44 (1): 32–8. doi:10.1210/jcem-44-1-32. PMID 833262.
- ↑ Fotherby K, Koetsawang S, Mathrubutham M (November 1980). "Pharmacokinetic study of different doses of Depo Provera". Contraception. 22 (5): 527–36. doi:10.1016/0010-7824(80)90105-5. PMID 6451351.
- ↑ "depo-subQ Provera" (PDF). FDA. 2017. Retrieved 31 March 2018.